BioRestorative Therapies (BRTX) to Release Quarterly Earnings on Friday

BioRestorative Therapies (NASDAQ:BRTX) is anticipated to issue its quarterly earnings data before the market opens on Friday, April 4th. Analysts expect the company to announce earnings of ($0.27) per share and revenue of $0.48 million for the quarter.

BioRestorative Therapies (NASDAQ:BRTX) last issued its quarterly earnings data on Thursday, March 27th. The company reported ($0.20) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.07. The business had revenue of $0.50 million for the quarter, compared to analyst estimates of $0.48 million. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. On average, analysts expect BioRestorative Therapies to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

BioRestorative Therapies Stock Performance

NASDAQ:BRTX opened at $1.78 on Wednesday. The stock’s 50-day moving average is $1.96 and its 200-day moving average is $1.73. The stock has a market cap of $12.32 million, a P/E ratio of -1.16 and a beta of 64.37. BioRestorative Therapies has a 1-year low of $1.03 and a 1-year high of $2.55.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.